Rajiv Kumar

22PUBLICATIONS
126CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 08, 2026
Association Between pTERT Promoter Mutation Subtypes and Survival Outcomes in BRAF-Mutant Metastatic Melanoma Treated With BRAF/MEK Inhibitors: An Exploratory Study.

|Oct 23, 2021
Mutational Characterization of Cutaneous Melanoma Supports Divergent Pathways Model for Melanoma Development.

David Millán-Esteban, María Peña-Chilet, Zaida García-Casado

|Jul 27, 2021
Occurrence, functionality and abundance of the TERT promoter mutations.

Sivaramakrishna Rachakonda, Jörg D Hoheisel, Rajiv Kumar

|Oct 30, 2020
Association of HERV-K and LINE-1 hypomethylation with reduced disease-free survival in melanoma patients.

Maurizio Cardelli, Remco van Doorn, Lares Larcher

|Jul 05, 2020
Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.

Yan Dora Zhang, Amber N Hurson, Haoyu Zhang

|Jun 08, 2020
Clinical, environmental and histological distribution of BRAF, NRAS and TERT promoter mutations among patients with cutaneous melanoma: a retrospective study of 563 patients.

E Manrique-Silva, S Rachakonda, D Millán-Esteban

Pageof 4

Frequent Collaborators

9 joint publications

Eduardo Nagore

2 joint publications

Stuart MacGregor

2 joint publications

Maria Teresa Landi

2 joint publications

Miriam Potrony